Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
about
Hydrogel-based nanocomposites and mesenchymal stem cells: a promising synergistic strategy for neurodegenerative disorders therapyProtein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy.Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease.Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models.Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria.Vascular Endothelial Growth Factor Enhanced the Angiogenesis Response of Human Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Radiation Myelopathy.Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis.RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review.Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model.HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway.Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system.Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system.Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.Surface markers for chondrogenic determination: a highlight of synovium-derived stem cells.Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies.Hydrogels for central nervous system therapeutic strategies.Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Stem cell therapies in age-related neurodegenerative diseases and stroke.The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms.Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells.Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice.Autophagy gene FIP200 in neural progenitors non-cell autonomously controls differentiation by regulating microglia.Microglia and astrocytes in Alzheimer's disease: implications for therapy.Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats.Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Aß25-35 administration.Mesenchymal Stem Cells as Treatment for Behavioral Deficits and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms.Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers.Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.Recent Advances: Decoding Alzheimer's Disease With Stem Cells.Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice.
P2860
Q27027614-F7811FA6-A374-4C86-B9D0-6083F37FE364Q33722176-86B1DBF2-3F0F-46AC-BA4D-EFA70796BC08Q33750881-D98C5E02-7FF4-4B53-8874-5E4C52A0A6FAQ33964297-C4D18B3E-81C2-47A5-B377-6A4753E84F7DQ34408378-B8953BA6-FA94-489E-B41C-CC3F78EC52B0Q35319897-28949866-CED3-4517-B2DD-10B6F3F83EB6Q35711050-4728E550-4532-4975-B3F7-25A0B0506AE2Q35733211-7A992AD3-CC5C-4A33-8BFA-CE689DF6A877Q35837904-447ED9A1-8831-4D9B-960D-132F7AED87A3Q36309612-B2782AF6-9830-4277-BBB5-0F48A8B68049Q36413131-19B58A7D-07E0-4FC8-B4FA-68208367B559Q37372219-95EBF53E-801F-41FE-BE0A-50357E04053BQ37582089-64134E9B-03D6-4CCB-B3CC-6483C04C28D8Q37677012-C612DCA0-2A3D-4920-A506-8ADEB7573B34Q38088965-8CFA1DAA-7D4D-48C6-92D5-5947AD800CBAQ38098448-B3154234-3643-4C7F-BB48-7A4BEDE47370Q38127753-19515403-43FE-489E-A6B2-864B77D888F3Q38133632-BF100605-AA41-48BB-8B85-71582D174EFDQ38151732-D4B8A8C6-C95E-42EA-A85C-B4ABE38F1585Q38177234-5C7FCC5D-5998-4B4D-AD94-C2C4D0353C1EQ38185612-8D72DDD0-D234-45F6-8B5B-8DAAE07F6513Q38202880-AD199286-DF3A-412A-BA59-2DD3C9DAA168Q38539382-1E111B47-041C-4A9A-A0D6-A713DCE304EAQ38651258-851FEEB9-4F82-4D07-AD93-597BE5982133Q38843285-1611352C-D62D-4D1A-BBB6-ED430671BB24Q38999345-2BD50233-870D-4A61-ABB0-B5D52E8B27E5Q39017141-A66D11A4-19FA-4B7A-83EB-3F0DCEB3D50EQ42154667-EEBC39EA-9121-4143-A2B9-FC1195F4A55CQ42323226-CAF799FF-DC1D-4418-887E-AE12560F9CA3Q47882404-19B1627A-CDCC-4250-9867-0DCCE358E4D6Q48000367-7D5AB0A3-91C9-4262-B081-9F5F3506146CQ48185740-08B67103-0C97-4942-BF78-CBEE025CE8D2Q48346065-BCC82D69-DD93-4CD1-B68F-5246865135D8Q48460467-DD26D59A-18B0-479A-9ED1-DF05FA02F326Q48925135-53DA2770-3A27-48BC-B745-0011B4F49B8DQ50466351-EF0E37A8-AFAE-44EE-B9D3-1D4B6BF450A4Q50543411-3F6AABE4-16C8-4EF9-B1D0-C615CD0DD39DQ52584637-944CFC1F-CFC1-4880-AA97-639EA40AD26DQ52603658-A0B44DDB-168A-4B6B-819E-EE2761EA0070Q54217663-596E0FC2-CC54-4362-AC3D-A8BD3938B795
P2860
Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@en
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@nl
type
label
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@en
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@nl
prefLabel
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@en
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@nl
P2093
P2860
P356
P1433
P1476
Soluble CCL5 derived from bone ...... ed microglia immune responses.
@en
P2093
Edward H Schuchman
Hee Kyung Jin
Jae-sung Bae
Jong Kil Lee
P2860
P304
P356
10.1002/STEM.1125
P577
2012-07-01T00:00:00Z